1-2 of 2
Maria-Elvira González Valentin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

Albert Oriol, MD, Pilar Bastida, MD, Olga García, Carlota Calvo, Juan-Manuel Perez-Hurtado, Maria-Elvira González Valentin, Jose Luis Fuster, MD, Izaskun Egurbide, Victoria Martin-Reina, Antonio Molines, MD, Javier Lassaletta, Miguel-Angel Sanz, Mar Tormo, Mercedes Carnero, Juan-José Ortega, Josep-Maria Ribera, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2026.
https://doi.org/10.1182/blood.V114.22.2026.2026
Published: 2009
Journal Articles

Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Children with Very High-Risk Acute Lymphoblastic Leukemia (VHR-ALL). Final Results of the PETHEMA ALL-93 Trial.

Josep-Maria Ribera, PhD, Juan-Jose Ortega, MD, Albert Oriol, MD, Pilar Bastida, MD, Carlota Calvo, MD, Jose-María Perez-Hurtado, MD, Maria-Elvira González-Valentin, MD, Vicky Martin-Reina, MD, Antonio Molines, MD, Fernando Ortega-Rivas, MD, Maria-Pilar Queipo, MD, Concepción Rivas, MD, Izaskun Egurbide, MD, Inmaculada Heras, MD, Concepción Poderos, MD, Eva Martínez-Revuelta, MD, Jose-Maria Guinea, MD, Eloy del Potro, MD, Guillermo Deben, MD
Journal: Blood
Blood (2005) 106 (11): 173.
https://doi.org/10.1182/blood.V106.11.173.173
Published: 2005